← BLACKLEDGER Content Feed

Selling • NEUROPHAGE x BLACKLEDGER • 9 min read • 2026-08-01

BLACKLEDGER Selling Watch: HIVE, SHOP, DKNG

BLACKLEDGERMarket ResearchSellingHIVESHOPDKNGRIVN
BLACKLEDGER Selling public market research update for HIVE, SHOP, DKNG

BLACKLEDGER's latest selling watch update tracks HIVE, SHOP, DKNG, RIVN, DNN, VKTX from the active public watchlist. This post is built from public-safe status data, in-house public signal labels, and outside public source context. It is designed to help readers understand what is happening around each asset without exposing private research methods.

Selling Watch Data

The dedicated feed category for this update is Selling. The latest public scan timestamp is 2026-08-01T08:00:05.121034+00:00.

Educational Context: How To Use This Page

This page is not a trade instruction. It is an educational research brief. Readers can use it to understand company or project background, public market context, public status labels, and relevant outside-source headlines before doing their own due diligence.

HIVE Public Research Bio

Name: HIVE Digital Technologies Ltd.. Market class: stock. Public bias: Bear. Public tier: Extended.

HIVE Digital Technologies Ltd., a technology company, engages in the building and operating data centers powered by green energy in Bermuda, Paraguay, Sweden, and Canada. The Company operates the mining and sale of digital currencies and performance computing hosting. It also provides infrastructure solutions, such as computational capacity to distributed networks in the blockchain industry. The company was formerly known as HIVE Blockchain Technologies Ltd. and changed its name to HIVE Digital Technologies Ltd. in July 2023. HIVE Digital Technologies Ltd. was incorporated in 1987 and is headquartered in San Antonio, Texas.

Why HIVE Is In This Public Update

Outside Public Headlines / Source Notes

SHOP Public Research Bio

Name: Shopify Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.

Shopify Inc., a commerce technology company, provides tools to start, scale, market, and run a business of various sizes in Canada, the United States, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The Company offers Shopify platform that enables merchants to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics, and reporting and access financing for running their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts, and marketplaces. It also provides Shopify Payments, a fully integrated payment processing service that allows merchants to accept and process payment cards online and offline. In addition, the company engages in the sale of themes and apps; shipping labels through Shopify Shipping; point-of-sale hardware; advertising on the

Why SHOP Is In This Public Update

Outside Public Headlines / Source Notes

DKNG Public Research Bio

Name: DraftKings Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.

DraftKings Inc. operates as a digital sports entertainment and gaming company in the United States and internationally. The company offers online and retail sports betting, daily fantasy sports, digital lottery couriers, prediction markets, and other products, as well as retails sportsbooks. It also provides iGaming, or online casino products, which includes blackjack, roulette, baccarat and slot machines. In addition, the company engages in the design and development of sports betting and casino gaming software for online and retail sportsbooks, and iGaming operators. DraftKings Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.

Why DKNG Is In This Public Update

Outside Public Headlines / Source Notes

RIVN Public Research Bio

Name: Rivian Automotive, Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.

Rivian Automotive, Inc., together with its subsidiaries, develops, manufactures, and sells category-defining electric vehicles. It operates through two segments, Automotive, and Software and Services. The company offers consumer vehicles, including a two-row, five-passenger pickup truck under the R1T brand; and a three-row, seven-passenger sport utility vehicle under the R1S name. It also provides software and services, such as vehicle electrical architecture and software development, as well as Autonomy+, r[redacted]rketing, vehicle repair and maintenance services, software subscriptions, vehicle accessories, financing, insurance, and other services. In addition, the company designs, develops, and manufactures the Rivian Adventure Network Direct Current fast chargers; and FleetOS, a proprietary, end-to-end centralized fleet management subscription platform. Further, it offers Rivian Commercial Van platform for Electric Delivery Van wit

Why RIVN Is In This Public Update

Outside Public Headlines / Source Notes

DNN Public Research Bio

Name: Denison Mines Corp.. Market class: stock. Public bias: Bear. Public tier: Extended.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. It holds 95% interest in its flagship project Wheeler River uranium project located in the Athabasca Basin region in northern Saskatchewan. The company was formerly known as International Uranium Corporation and changed its name to Denison Mines Corp. in December 2006. The company was founded in 1954 and is headquartered in Toronto, Canada.

Why DNN Is In This Public Update

Outside Public Headlines / Source Notes

VKTX Public Research Bio

Name: Viking Therapeutics, Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystr

Why VKTX Is In This Public Update

Outside Public Headlines / Source Notes

What The Public Data Shows

The public feed highlights ticker status, market class, directional bias, score, tier, confidence, company or project profile, public market references, and outside-source headlines. These fields support a deeper view of BLACKLEDGER's public research feed while keeping private methods undisclosed.

Why This Category Matters

The Selling section gives readers a focused path through the market: buying watch content for constructive candidates, selling watch content for defensive movement, investing content for higher-quality public watch names, and market trend notes for broader context.

Research-Only Notice

BLACKLEDGER content is market research only. There is no live execution signal, no recommendation to buy or sell, and no financial advice. Readers should perform their own due diligence and consult licensed professionals before making financial decisions.

Research-only. No execution signal. Not financial advice.